Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
19.01
+0.61 (3.29%)
Jan 21, 2026, 11:50 AM EST - Market open
Evommune Stock Forecast
Stock Price Forecast
The 5 analysts that cover Evommune stock have a consensus rating of "Strong Buy" and an average price target of $38.6, which forecasts a 103.10% increase in the stock price over the next year. The lowest target is $35 and the highest is $42.
Price Target: $38.6 (+103.10%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Evommune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 |
|---|---|---|
| Strong Buy | 0 | 2 |
| Buy | 5 | 5 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +110.47% | Jan 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +84.16% | Jan 6, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $36 | Buy | Initiates | $36 | +89.42% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
13.26M
from 7.00M
Increased by 89.43%
Revenue Next Year
n/a
from 13.26M
EPS This Year
-4.25
from -45.29
EPS Next Year
-2.87
from -4.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 13.7M | n/a | |
| Avg | 13.3M | n/a | |
| Low | 12.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 95.0% | - | |
| Avg | 89.4% | - | |
| Low | 82.0% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.63 | -2.67 | |
| Avg | -4.25 | -2.87 | |
| Low | -7.05 | -3.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.